Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

Irving, Texas

Phase 1 colorectal cancer trials in Irving, TX

15 Phase 1 colorectal cancer studies are recruiting participants at sites in Irving as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Irving at a glance

  • 15 studies are recruiting at a site in Irving.
  • By phase: Phase 1 (10), Phase 1/2 (5).
  • By sponsor: industry (15).
  • Most recent update to one of these records: November 13, 2026.

Studies recruiting in Irving

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    Next Oncology - Dallas
    Registry record
    NCT07488676 · updated
  2. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    NEXT Texas LLC - Dallas
    Registry record
    NCT07503808 · updated
  3. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    NEXT Dallas
    Registry record
    NCT07397338 · updated
  4. A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Immunome, Inc.
    Study site
    NEXT Dallas
    Registry record
    NCT07578571 · updated
  5. A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Inc
    Study site
    NEXT Oncology Dallas
    Registry record
    NCT07094204 · updated
  6. Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Sutro Biopharma, Inc.
    Study site
    NEXT Oncology Dallas
    Registry record
    NCT07807345 · updated
  7. A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    Next Oncology Dallas /ID# 284346
    Registry record
    NCT07807956 · updated
  8. AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Avacta Life Sciences Ltd
    Study site
    NEXT Oncology
    Registry record
    NCT07454642 · updated
  9. A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Bayer
    Study site
    NEXT Dallas - Oncology Department
    Registry record
    NCT07535112 · updated
  10. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Study site
    Exelixis Clinical Site #73
    Registry record
    NCT05176483 · updated
  11. Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    NEXT Dallas
    Registry record
    NCT06128551 · updated
  12. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    NEXT Oncology Dallas
    Registry record
    NCT06445062 · updated
  13. A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    ArriVent BioPharma, Inc.
    Study site
    NEXT Dallas
    Registry record
    NCT07066657 · updated
  14. Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    Next Oncology Dallas /ID# 276254
    Registry record
    NCT05005403 · updated
  15. Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    MBrace Therapeutics
    Study site
    NEXT, Dallas
    Registry record
    NCT07145255 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Irving, TX on ClinicalTrials.gov.

Ask about studies near Irving

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Texas

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call